The 'Mass Spectrometry and Imaging Technologies in Geroscience1 P30 Core will consist of an integratedsuite of mass spectrometry and microscopic imaging technologies coupled to specific protein and smallmolecule drug and metabolite analysis assays and bioenergetic analysis.
The aims of this P30 Core are tointegrate the unique instrumentation facilities at the Buck Institute in imaging and mass spectrometry totarget the needs of the 10 components of the U54 in structural and functional proteomics, and for theanalysis of drugs and targeted metabolites that constitute this Geroscience initiative. Specifically, theimaging and mass spectrometry technologies will encompass; (i) functional and fixed-cell imaging usingprotein-specific fluorophores and antibodies, (ii) functional analysis of intact neurons and other cells includingbioenergetic and redox measurements, (iii) development and implementation of protein chemistries, (iv)mass spectrometry-based analysis of proteins, including their identification, quantitation, interactions andposttranslational modifications, (v) mass spectrometry imaging and profiling studies, and (vi) drug andmetabolite analyses. These studies will be carried out on a range of aging and aging-related disease modelsthat constitute the components of this U54. The P30 core will consist of two main but integrated parts:'Functional and Structural Imaging Technologies' directed by Dr. Nicholls and 'Mass SpectrometryTechnologies' directed by the principal investigator, Dr. Bradford Gibson. We propose to apply and integratethese instrument-based technologies at the very earliest stages of experimental design and work closely withthe other investigators to develop, optimize, and implement these mass spectrometry and imagingtechnologies.
Showing the most recent 10 out of 55 publications
